PATENT CLAIM ANALYSIS

Application Number: 15741949
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "172100"]

Abstract:
The present disclosure relates to antibodies having specificity to myosin 18A and uses thereof. In particular, the present disclosure relates to an antibody having specificity to myosin 18A comprising a heavy chain comprising i) a H-CDR1 having at least 90% of identity with the H-CDR1 of DY12, ii) a H-CDR2 having at least 90% of identity with the H-CDR2 of DY12 and iii) a H-CDR3 having at least 90% of identity with the H-CDR3 of DY12 and a light chain comprising i) a L-CDR1 having at least 90% of identity with the L-CDR1 of DY12, ii) a L-CDR2 having at least 90% of identity with the L-CDR2 of DY12 and iii) a L-CDR3 having at least 90% of identity with the L-CDR3 of DY12.

Claim (Index 21):
The method according to  claim 20 , wherein the method is a method of treating cancer in a subject in need thereof and comprises administering to the subject a first antibody selective for a cancer cell antigen, and administering to the subject the antibody of  claim 1 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 3.27907
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15100060', '15271861', '15167166', '14025573', '15034350']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7255656209424424
- 35 USC 102 Novelty (BERT): 0.5498739161764618
- Combined Prediction Score: 0.7079964504658444
- Mean Citation Score: 377.420622
- Max Citation Score: 400.38882
- Similarity Product: 283.583967640332

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test